{"slideshow_credits": null, "snippet": "The foundation is to announce that it will receive $3.3 billion after it helped finance the development of drugs for the deadly lung disease.", "abstract": "Cystic Fibrosis Foundation, announcing it will receive $3.3 billion from selling the royalties to new drugs for deadly lung disease, opens door to conflict of interest claims; not-for-profit dedicated to helping patients invested in biotech company 15 years ago and new-found money is result of that research; critics say CFF should not profit, but instead help reduce cost of drugs for patients.", "section_name": "Business Day", "print_page": "1", "document_type": "article", "byline": {"person": [{"firstname": "Andrew", "role": "reported", "lastname": "POLLACK", "rank": 1, "organization": ""}], "original": "By ANDREW POLLACK", "contributor": ""}, "web_url": "http://www.nytimes.com/2014/11/19/business/for-cystic-fibrosis-foundation-venture-yields-windfall-in-hope-and-cash.html", "lead_paragraph": "The foundation is to announce that it will receive $3.3 billion after it helped finance the development of drugs for the deadly lung disease.", "headline": {"main": "Deal by Cystic Fibrosis Foundation Raises Cash and Some Concern", "print_headline": "Deal by Cystic Fibrosis Group Raises Cash and Some Concern"}, "_id": "546c242438f0d869ced9a6fd", "word_count": "1150", "multimedia": [{"height": 126, "url": "images/2014/11/19/business/Royal1/Royal1-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2014/11/19/business/Royal1/Royal1-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 400, "url": "images/2014/11/19/business/Royal1/Royal1-articleLarge.jpg", "legacy": {"xlarge": "images/2014/11/19/business/Royal1/Royal1-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "400"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2014/11/19/business/Royal1/Royal1-thumbStandard.jpg", "legacy": {"thumbnail": "images/2014/11/19/business/Royal1/Royal1-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2014-11-19T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"value": "Cystic Fibrosis", "name": "subject", "is_major": "Y", "rank": "1"}, {"value": "Cystic Fibrosis Foundation", "name": "organizations", "is_major": "Y", "rank": "2"}, {"value": "Drugs (Pharmaceuticals)", "name": "subject", "is_major": "Y", "rank": "3"}, {"value": "Conflicts of Interest", "name": "subject", "is_major": "Y", "rank": "4"}, {"value": "Royalties", "name": "subject", "is_major": "N", "rank": "5"}, {"value": "Vertex Pharmaceuticals Inc", "name": "organizations", "is_major": "N", "rank": "6"}, {"value": "Royalty Pharma", "name": "organizations", "is_major": "N", "rank": "7"}], "blog": [], "subsection_name": null, "type_of_material": "News"}